Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oncorus Inc
(NQ:
ONCR
)
N/A
UNCHANGED
Last Price
Updated: 11:52 AM EDT, Jun 20, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Oncorus Inc
Oncorus Announces Workforce Reduction Plan
June 01, 2023
From
Oncorus, Inc.
Via
GlobeNewswire
Oncorus Reports First Quarter 2023 Financial Results and Provides Business Updates
May 22, 2023
From
Oncorus, Inc.
Via
GlobeNewswire
Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
March 24, 2023
From
Oncorus, Inc.
Via
GlobeNewswire
4 Stocks With Huge Cash Holdings at Silicon Valley Bank
March 13, 2023
How the recent failure of Silicon Valley Bank leaves several companies with significant deposits stuck in the bank. Will regulators step in and save the day?
Via
MarketBeat
Topics
ETFs
Economy
Exposures
Interest Rates
Oncorus Announces Research Collaboration with Daewoong Pharmaceutical for the Development of Lipid Nanoparticle Formulations for mRNA Drug Candidates
January 04, 2023
From
Oncorus, Inc.
Via
GlobeNewswire
Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with Cancer
November 30, 2022
From
Oncorus, Inc.
Via
GlobeNewswire
Oncorus to Participate in Upcoming Investor Conferences
November 23, 2022
From
Oncorus, Inc.
Via
GlobeNewswire
Oncorus Presents Preclinical Data Supporting ONCR-719, an armed HSV-1 Vector engineered to use the Epidermal Growth Factor Receptor (EGFR/EGFRvIII) for viral entry in Glioblastoma, at the 2022 Society for Neuro-Oncology Annual Meeting
November 18, 2022
From
Oncorus, Inc.
Via
GlobeNewswire
Oncorus Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 02, 2022
From
Oncorus, Inc.
Via
GlobeNewswire
Oncorus Announces Publication in Nature Communications Highlighting the Development of its Intravenously Administered Synthetic vRNA/LNP Platform for the Treatment of Cancer
October 07, 2022
New preclinical results support self-amplifying vRNA/LNP immunotherapy platform and ongoing IND-enabling studies of ONCR-021
From
Oncorus, Inc.
Via
GlobeNewswire
DPS Group Tapped by Oncorus to Design GMP Clinical Manufacturing Facility
September 22, 2021
Clinical stage biopharmaceutical company focused on viral immunotherapies building out state-of-the-art, 88,000 square foot facility in Massachusetts BOSTON, MA / ACCESSWIRE / September 22, 2021 / DPS...
From
DPS Group - Boston
Via
AccessWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.